Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practice.
作者： Kurt Van der Speeten , Lieselotte Lemoine , Paul Sugarbaker
DOI: 10.1515/PP-2017-0003
关键词:
摘要: Peritoneal surface malignancy (PSM) is a common manifestation of digestive and gynecologic malignancies alike. At present, patients with isolated PSM are treated combination therapy cytoreductive surgery (CRS) hyperthermic intraperitoneal chemotherapy (HIPEC). The CRS (IP) should now be considered standard care for from appendiceal epithelial cancers, colorectal cancer peritoneal mesothelioma. Although there near universal standardization regarding the CRS, we still lacking much-needed among various IP treatment modalities used today in clinical practice. Pharmacologic evidence generated to answer important questions raised by myriad variables associated chemotherapy.
sci-hub.se 参考文章(84)
Eelco Bree, Dimitris D. Tsiftsis, Experimental and Pharmacokinetic Studies in Intraperitoneal Chemotherapy: From Laboratory Bench to Bedside Recent results in cancer research. ,vol. 169, pp. 53- 73 ,(2007) , 10.1007/978-3-540-30760-0_5
Doroshow Jh, Grotzinger Kr, Locker Gy, Ozols Rf, Fisher Ri, Myers Ce, Young Rc, Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin. Cancer treatment reports. ,vol. 63, pp. 269- ,(1979)
Paul H. Sugarbaker, Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy. Cancer treatment and research. ,vol. 82, pp. 317- 325 ,(1996) , 10.1007/978-1-4613-1247-5_20
K Nagai, H Konishi, S Nogami, H Egusa, Pharmacokinetic evaluation of intraperitoneal doxorubicin in rats. Die Pharmazie. ,vol. 69, pp. 125- 127 ,(2014)
DeVita Vt, Dedrick Rl, Myers Ce, Bungay Pm, Pharmacokinetic rationale for peritoneal drug administration in the treatment of ovarian cancer Cancer treatment reports. ,vol. 62, pp. 1- 11 ,(1978)
Lucas Sideris, Yves E. Leclerc, Pierre Drolet, Pierre Dubé, Andrew Mitchell, Guy Leblanc, Surgical cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis arising from the appendix. Canadian Journal of Surgery. ,vol. 52, pp. 135- 141 ,(2009)
Paul H. Sugarbaker, P. Schlag, E. A. DeBruijn, W. J. Cunliffe, R. E. Mullins, T. Graves, W. E. Hull, L. Oliff, Early Postoperative Intraperitoneal Chemotherapy as an Adjuvant Therapy to Surgery for Peritoneal Carcinomatosis from Gastrointestinal Cancer: Pharmacological Studies Cancer Research. ,vol. 50, pp. 5790- 5794 ,(1990)
Benjamin Drewinko, Barthel Barlogie, Peter M. Corry, In vitro thermochemotherapy of human colon cancer cells with cis-dichlorodiammineplatinum(II) and mitomycin C. Cancer Research. ,vol. 40, pp. 1165- 1168 ,(1980)
Paul H. Sugarbaker, James L. Speyer, Charles E. Myers, Raymond Greene, Jean Jenkins, Robert F. Ozols, Robert C. Young, Phase I and Pharmacological Studies of Adriamycin Administered Intraperitoneally to Patients with Ovarian Cancer Cancer Research. ,vol. 42, pp. 4265- 4269 ,(1982)
J. Gordon McVie, Glenn S. Baldew, Peter H. A. Mutsaers, Peter W. de Graaf, Gerrit Los, Wim J. F. van der Vijgh, Direct Diffusion of cis-Diamminedichloroplatinum(II) in Intraperitoneal Rat Tumors after Intraperitonal Chemotherapy: A Comparison with Systemic Chemotherapy Cancer Research. ,vol. 49, pp. 3380- 3384 ,(1989)